The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute
on Aging is also expected to release the results of research on the safety of testosterone. The study included about 800 older men with low testosterone and symptoms associated with this condition, including http://tinyurl.com/zj86oxg
physical and sexual dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent conflicting findings on testosterone therapy prompted Patel and his team to conduct a sizeable systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in America have problems with low testosterone, which happens when the body doesn't make enough hormones because of a problem with the testicles or pituitary gland. This clarifies the unexpected weight gain, obvious aging and loss of energy of a person.
And many women have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a vital role
in warding off the disease. Glaser believes this will probably stay the status quo for a little while, given the prohibitive cost of running the long-term safety studies needed to win FDA acceptance that is completer.